BridgeBio Soars After Drug Gets Nod in Rare Heart Condition
CTIGX Fund | USD 16.88 0.09 0.53% |
Slightly above 62% of Calamos Timpani's investor base is looking to short. The analysis of overall sentiment of trading Calamos Timpani Smid mutual fund suggests that many investors are alarmed at this time. Calamos Timpani's investing sentiment can be driven by a variety of factors including economic data, Calamos Timpani's earnings reports, geopolitical events, and overall market trends.
Calamos |
-- BridgeBio Pharma Inc. jumped the most in 16 months after its drug got US regulators nod to treat a rare, deadly form of heart disease, paving the way for head-to-head competition with medications from Pfizer Inc.Most Read from BloombergNYCs Underground Steam System May Be Key to a Greener FutureIn Kansas City, a First-Ever Stadium Designed for Womens Sports Takes the FieldNYC Gets Historic Push for 80,000 Homes With 5 Billion PledgeNew York Citys Living Breakwaters Brace fo
Read at finance.yahoo.com
Calamos Timpani Fundamental Analysis
We analyze Calamos Timpani's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Calamos Timpani using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Calamos Timpani based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
One Year Return
One Year Return Comparative Analysis
Calamos Timpani is currently under evaluation in one year return among similar funds. One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
Calamos Timpani Smid Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Calamos Timpani mutual fund to make a market-neutral strategy. Peer analysis of Calamos Timpani could also be used in its relative valuation, which is a method of valuing Calamos Timpani by comparing valuation metrics with similar companies.
Peers
Calamos Timpani Related Equities
CVGCX | Calamos Growth | 0.77 | ||||
SROCX | Calamos Antetokounmpo | 0.47 | ||||
SROAX | Innealta Capital | 0.46 | ||||
SRORX | Calamos Antetokounmpo | 0.46 | ||||
SROIX | Calamos Antetokounmpo | 0.46 | ||||
CVACX | Calamos Opportunistic | 0.37 | ||||
CVAIX | Calamos Opportunistic | 0.37 | ||||
CVAAX | Calamos Opportunistic | 0.34 | ||||
CVLOX | Calamos Global | 0.30 | ||||
CVGRX | Calamos Growth | 0.00 |
Other Information on Investing in Calamos Mutual Fund
Calamos Timpani financial ratios help investors to determine whether Calamos Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Calamos with respect to the benefits of owning Calamos Timpani security.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |